Search Results - "Castillo Villegas, D."
-
1
Association of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
2
Association of immune-related adverse (irAEs) with immune-checkpoint inhibitors (ICIs) efficacy in solid tumors
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
3
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
Published in The lancet respiratory medicine (01-05-2020)“…The INBUILD trial investigated the efficacy and safety of nintedanib versus placebo in patients with progressive fibrosing interstitial lung diseases (ILDs)…”
Get full text
Journal Article Web Resource -
4
Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain: the SEPAR National Registry
Published in Respiratory research (17-06-2019)“…Little is known on the characteristics of patients diagnosed with idiopathic pulmonary fibrosis (IPF) in Spain. We aimed to characterize the demographic and…”
Get full text
Journal Article -
5
1409PAssociation of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
6
1201PAssociation of immune-related adverse (irAEs) with immune-checkpoint inhibitors (ICIs) efficacy in solid tumors
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
7
Triple terapia en fibrosis pulmonar idiopática
Published in Archivos de bronconeumología (01-06-2014)Get full text
Journal Article